FDA-Drug2025-08-06Class II
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Hikma Pharmaceuticals USA Inc.
Hazard
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
Sold states
Distributed Nationwide in the USA
Affected count
382,775 1mL vials
Manufactured in
2 Esterbrook Ln, Cherry Hill, NJ, United States
Products
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0551-2025Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief